The High Five-Year Survival Rate of Early-Stage Colorectal Cancer and the Importance of Accurate Cancer Staging

How is Colorectal Cancer Staged?

Colorectal cancer staging can be divided into "pre-operative imaging staging" and "post-operative pathological staging," determined by factors such as the depth of invasion of the cancer cells into the intestinal wall, regional lymph node metastasis, and the presence of distant organ metastasis.

Precise Diagnosis and Staging Lead to Optimal Treatment Outcomes

Colorectal cancer is initially divided into four stages, with in-situ cancer referred to as stage 0, and invasive cancers categorized into stages 1 through 4. A tumor that invades the submucosa or muscular layer of the intestine is considered stage 1; invasion beyond the intestinal wall indicates stage 2; regional lymph node metastasis signifies stage 3; and distant organ metastasis denotes stage 4. Stages 2 to 4 can be further subdivided into stages A, B, and C, based on the depth of invasion, the number of lymph nodes affected, and the presence of distant metastases. Such detailed staging is crucial for understanding the severity of the disease, predicting treatment outcomes, and most importantly, for "determining the treatment approach." For example, stage 3 colorectal cancer requires post-operative chemotherapy in addition to surgical removal to reduce the chances of recurrence. For stage 4 cancers, targeted therapy might be necessary in addition to standard chemotherapy. Treatment varies significantly across different stages.

Early-Stage Colorectal Cancer Boasts a High Five-Year Survival Rate

With the widespread adoption of fecal occult blood screening, the proportion of patients diagnosed in stages 1 and 2 has increased. Before the prevalence of screening, most patients were diagnosed in stage 3 or even stage 4. Early detection means earlier stages at diagnosis, which generally leads to better treatment outcomes.

Currently, the overall five-year survival rate for colorectal cancer exceeds 60%, but the prognosis varies significantly by stage. Nationally, stage 1 patients have a five-year survival rate of up to 90%, stage 2 around 80%, stage 3 drops to 60-70%, and stage 4 less than 30%. KFSYSCC's stage 1 to 3 colorectal cancer patients have a five-year survival rate about 5 to 10% higher than the national average. Unfortunately, treatment for stage 4 patients remains challenging, often due to their weakened condition upon arrival and the limited treatment options after undergoing extensive therapies elsewhere. However, with advancements in medication, the condition of stage 4 patients can often be managed for over two years, with hope for even more effective treatments in the future.

Seeking a Second Opinion to Ensure Quality and Safety of Treatment

Stage 0, where cancer cells are confined to the mucosal layer, typically does not involve lymph node metastasis and can usually be entirely removed via colonoscopy, eliminating the need for surgical removal of part of the intestine. The depth and extent of cancer cell invasion require professional judgment by a pathologist. Interpretations can vary from one hospital's pathology department to another, so if a doctor diagnoses in-situ cancer and later stages show metastasis, the initial staging might have been inaccurate. Therefore, if you're diagnosed with cancer cells at one hospital, it's advisable to seek a second opinion or even a second pathological evaluation at another institution for more assurance in your treatment plan.